Investors

Corporate Governance

Audit committee

Barbara Duncan

Audit Committee Chair
ObsEva Board of Directors

Frank Verwiel, MD

Member
Chairperson, ObsEva Board of Directors

Ed Mathers

Partner, NEA (U.S.A.)Member, ObsEva Board of Directors

Compensation, Nominating and Corporate Governance Committee

Annette Clancy, BSc (Hons)

Member
ObsEva Board of Directors

James I. Healy, MD, PhD

General Partner, Sofinnova Investments (U.S.A.)Member, ObsEva Board of Directors

Ed Mathers

Partner, NEA (U.S.A.)Member, ObsEva Board of Directors

Rafaèle Tordjman, MD, PhD

Member
ObsEva Board of Directors

 
 

Sign up for news

 
 

* Type:


InvestorHCPNursePayerHospital PharmacistRetail PharmacistOther












Read our privacy policy here.

 

Are you sure you want to leave ObsEva.com?

We’re sorry to see you go. Choose one of the following actions to stay on the site or leave.

Continue to link

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue